9 | Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
08/2009
-
09/2005 |
6 | Proteins (Proteins, Gene)FDA Link
09/2021
-
11/2006 |
3 | muconomycin AIBA
09/2013
-
02/2013 |
3 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2013
-
12/2011 |
3 | LigandsIBA
05/2013
-
12/2011 |
3 | NF-kappa B (NF-kB)IBA
04/2008
-
08/2005 |
2 | FlavonoidsIBA
05/2022
-
12/2019 |
2 | EnzymesIBA
01/2022
-
12/2019 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
-
03/2018 |
2 | STK899704IBA
01/2018
-
01/2017 |
2 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2015
-
07/2012 |
2 | TensinsIBA
09/2015
-
07/2012 |
2 | Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2015
-
07/2012 |
2 | Phosphatidylinositols (Phosphatidylinositol)IBA
09/2015
-
05/2011 |
1 | GlycosidesIBA
08/2022 |
1 | PolyketidesIBA
08/2022 |
1 | kurarinoneIBA
05/2022 |
1 | AcetylcholinesteraseIBA
01/2022 |
1 | Oxidopamine (6 Hydroxydopamine)IBA
12/2021 |
1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2021 |
1 | pipecolic acidIBA
01/2021 |
1 | DepsipeptidesIBA
01/2021 |
1 | beauvericinIBA
04/2020 |
1 | Death Domain ReceptorsIBA
04/2020 |
1 | streptimidoneIBA
01/2020 |
1 | Tryptophan (L-Tryptophan)FDA Link
12/2019 |
1 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
12/2019 |
1 | TransferasesIBA
05/2019 |
1 | DNA (Deoxyribonucleic Acid)IBA
05/2019 |
1 | DecitabineFDA Link
05/2019 |
1 | Peptide Nucleic AcidsIBA
11/2018 |
1 | Filaggrin ProteinsIBA
11/2018 |
1 | Peptides (Polypeptides)IBA
10/2018 |
1 | elaiophylinIBA
03/2018 |
1 | Angiogenesis InhibitorsIBA
03/2018 |
1 | Fluorouracil (Carac)FDA LinkGeneric
01/2018 |
1 | Tubulin ModulatorsIBA
01/2018 |
1 | Polo-Like Kinase 1IBA
01/2018 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2017 |
1 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2017 |
1 | eupafolinIBA
09/2015 |
1 | pectate lyaseIBA
01/2015 |
1 | brassininIBA
07/2014 |
1 | 1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA
05/2014 |
1 | Melanins (Melanin)IBA
05/2014 |
1 | SesquiterpenesIBA
05/2014 |
1 | TrichothecenesIBA
09/2013 |
1 | salubrinalIBA
02/2013 |
1 | TNF-Related Apoptosis-Inducing LigandIBA
02/2013 |
1 | oligomycin AIBA
02/2013 |
1 | OligomycinsIBA
02/2013 |
1 | CamptothecinIBA
01/2013 |
1 | Etoposide (VP 16)FDA LinkGeneric
01/2013 |
1 | bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
01/2013 |
1 | 4,4'- (3H,3'H- 5,5'- bibenzimidazole- 2,2'- diyl)dianilineIBA
01/2013 |
1 | Antineoplastic Agents (Antineoplastics)IBA
11/2012 |
1 | geldanamycinIBA
11/2012 |
1 | Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2012 |
1 | aloe emodinIBA
07/2012 |
1 | Mechanistic Target of Rapamycin Complex 2IBA
07/2012 |
1 | DiketopiperazinesIBA
06/2012 |
1 | Oxepins (Oxepin)IBA
06/2012 |
1 | protuboxepin AIBA
06/2012 |
1 | ginsenoside Rh2IBA
06/2012 |
1 | Caspase 3 (Caspase-3)IBA
04/2012 |
1 | PatulinIBA
04/2012 |
1 | pregna-4,17-diene-3,16-dione (guggulsterone)IBA
12/2011 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
06/2011 |
1 | asperlinIBA
06/2011 |
1 | TunicamycinIBA
05/2011 |
1 | Proteasome InhibitorsIBA
05/2011 |
1 | MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
05/2011 |
1 | MitogensIBA
05/2011 |